2nd Quarter - Report

AMERICAN ASSOCIATION FOR CANCER RESEARCH for AMERICAN ASSOCIATION FOR CANCER RESEARCH

Firm
Client
Income
—
Expenses
$30,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2019 appropriations for the National Institutes of Health FY 2019 appropriations for the Food and Drug Administration STAR Act, H.R. 820

LobbyistCovered position, as disclosed
BRANDON LANE LEONARD New —
MARY LEE WATTS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 820 (115th)

Medical/Disease Research/Clinical Labs MED

cancer research oncology product review at the FDA pediatric cancer research and care

LobbyistCovered position, as disclosed
BRANDON LANE LEONARD New —
MARY LEE WATTS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Tobacco TOB

Tobacco control measures; e-cigarette regulation

LobbyistCovered position, as disclosed
MARY LEE WATTS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.